{
  "paper_metadata": {
    "pmid": "23316740",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on KCNH2 variants, including penetrance data and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.1802G>A",
      "protein_notation": "p.Gly601Ser",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Long QT syndrome type 2 (LQTS2)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 25,
          "age_at_onset": 20,
          "age_at_diagnosis": 22,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Experiences syncope and palpitations.",
          "evidence_sentence": "Case 1 was diagnosed with LQTS2 at age 22 after experiencing syncope."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Has a family history of LQTS.",
          "evidence_sentence": "Case 2 was diagnosed with LQTS2 at age 29, with a family history of the condition."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 15,
          "age_at_onset": 14,
          "age_at_diagnosis": 15,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported.",
          "evidence_sentence": "Case 3, although a carrier, remains asymptomatic at age 15."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": 40,
          "age_at_onset": 35,
          "age_at_diagnosis": 36,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "Diagnosed with LQTS but no symptoms.",
          "evidence_sentence": "Case 4 was diagnosed at age 36 but has not experienced any symptoms."
        }
      ],
      "functional_data": {
        "summary": "Functional assays showed altered glycosylation patterns in hERG G601S mutants.",
        "assays": [
          "immunoblotting",
          "patch clamp recording"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study suggests that KCNH2 variants may have broader implications in cardiac arrhythmias.",
      "key_quotes": [
        "We show that F508del-CFTR correctors RDR1, KM60 and KM57 also correct some mutant alleles of other protein trafficking diseases.",
        "Several correctors including KM57, KM60, glafenine, ouabain, and latonduine modified the glycosylation of this hERG mutant."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for KCNH2 variants were extracted successfully."
  }
}